1340480-33-2

Basic information

• Product Name: di-tert-butyl (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl phosphate
• Synonyms: di-tert-butyl (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl phosphate
• CAS NO: 1340480-33-2
• Molecular Weight: 668.009
• Mol File: 1340480-33-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: di-tert-butyl (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl phosphate(CAS DataBase Reference)
• NIST Chemistry Reference: di-tert-butyl (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl phosphate(1340480-33-2)
• EPA Substance Registry System: di-tert-butyl (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl phosphate(1340480-33-2)

Safety Data

• Hazardous Substances Data: 1340480-33-2(Hazardous Substances Data)

Upstream product

• 1155846-67-5 3-chloro-5-{[2-oxo-1-(1H-pyrazolo[3,4-b]pyridin-3-ylmethyl)-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl]oxy}benzonitrile 
• 229625-50-7 di-tert-butyl chloromethyl phosphate 

Downstream Products

• 1340480-34-3 (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl dihydrogenphosphate 
• 1340480-15-0 potassium (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl hydrogenphosphate 
• 1340480-16-1 (3-{[3-(3-chloro-5-cyanophenoxy)-2-oxo-4-(trifluoromethyl)pyridin-1(2H)-yl]methyl}-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl dihydrogenphosphate ammoniate 

Relevant articles and documents

PRODRUGS OF AN HIV REVERSE TRANSCRIPTASE INHIBITOR

Compounds of Formula I are described: (I), wherein RP and RQ are defined herein. The compounds of Formula I are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV, and the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.